These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9787953

  • 1. Polyclonal/monoclonal ratio in kidney and bone marrow transplanted patients treated with cyclosporine.
    Capone D, De Marino V, Caso N, Stanziale P, Fontana R, Imperatore P, De Marino V, Pisanti N.
    Clin Transplant; 1998 Oct; 12(5):430-3. PubMed ID: 9787953
    [Abstract] [Full Text] [Related]

  • 2. Effects of different routes of cyclosporin A administration on blood levels in patients undergoing bone marrow transplantation.
    Capone D, De Marino V, Fontana R, Notaro R, De Marino V, Pisanti N.
    Bone Marrow Transplant; 1997 Feb; 19(4):369-72. PubMed ID: 9051247
    [Abstract] [Full Text] [Related]

  • 3. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
    Stephens E, Bolderson I, Clark B, Kinsey S, Gooi HC, Cook G.
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of monoclonal/polyclonal ratio in kidney-transplanted patients treated with cyclosporine.
    Capone D, Stanziale P, Balletta MM, Imperatore P, De Marino V, Pisanti N.
    Int J Clin Pharmacol Res; 1992 Sep; 12(3):123-8. PubMed ID: 1473878
    [Abstract] [Full Text] [Related]

  • 5. Drug interaction between cyclosporine and two antimicrobial agents, josamycin and rifampicin, in organ-transplanted patients.
    Capone D, Aiello C, Santoro GA, Gentile A, Stanziale P, D'Alessandro R, Imperatore P, Basile V.
    Int J Clin Pharmacol Res; 1996 Sep; 16(2-3):73-6. PubMed ID: 9063759
    [Abstract] [Full Text] [Related]

  • 6. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA, van Dam T, Metselaar HJ, Balk AH, Mathôt RA, Smak Gregoor PJ, Weimar W, van Gelder T.
    Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
    [Abstract] [Full Text] [Related]

  • 7. [Problems associated with the use and monitoring of cyclosporin. Experience at a Clinical Pharmacology Service].
    Loffreda A, Contaldi C, Santis DD, Marabese I, Chiaiese C, Formato P, Motola G, Russo F, D'Alessio O, Lampa E, Rossi F.
    Minerva Med; 1997 Dec; 88(12):543-9. PubMed ID: 9540786
    [Abstract] [Full Text] [Related]

  • 8. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M, Kainz A, Schillinger M, Posch C, Birsan T, Rasoul-Rockenschaub S, Böhmig GA, Schmaldienst S, Watschinger B, Hörl WH, Mühlbacher F, Säemann MD.
    Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
    [Abstract] [Full Text] [Related]

  • 9. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 10. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients.
    Mück W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S, Johne A, Bauer S, Budde K, Roots I, Neumayer HH, Kuhlmann J.
    Clin Pharmacol Ther; 1999 Mar; 65(3):251-61. PubMed ID: 10096257
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR, Singh S.
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [Abstract] [Full Text] [Related]

  • 12. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT.
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine A assays: comparison between radioimmunoassay and fluorescent polarization immunoassay technique by TDx, and the clinical significance of the polyclonal:monoclonal TDx ratio.
    McKenna BA, Pabico RC, Cerilli GJ.
    Transplant Proc; 1994 Oct; 26(5):2818-9. PubMed ID: 7940886
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring.
    Sharma A, Shekhar C, Heer M, Minz M.
    Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996
    [Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels.
    Mercanoglu F, Turkmen A, Kocaman O, Pinarbasi B, Dursun M, Selcukbiricik F, Sever MS.
    Transplant Proc; 2004 Jun; 36(5):1357-60. PubMed ID: 15251332
    [Abstract] [Full Text] [Related]

  • 16. Hyperkalemia associated with cyclosporine (CsA) use in bone marrow transplantation.
    Fleming DR, Ouseph R, Herrington J.
    Bone Marrow Transplant; 1997 Feb; 19(3):289-91. PubMed ID: 9028560
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine metabolism in patients after kidney, bone marrow, heart-lung, and liver transplantation in the early and late posttransplant periods.
    Hamwi A, Salomon A, Steinbrugger R, Fritzer-Szekeres M, Jäger W, Szekeres T.
    Am J Clin Pathol; 2000 Oct; 114(4):536-43. PubMed ID: 11026099
    [Abstract] [Full Text] [Related]

  • 18. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers.
    Marchewka Z, Kuźniar J, Zynek-Litwin M, Falkiewicz K, Szymańska B, Roszkowska A, Klinger M.
    Transplant Proc; 2009 Jun; 41(5):1660-5. PubMed ID: 19545703
    [Abstract] [Full Text] [Related]

  • 19. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T.
    Transplantation; 2003 Oct 27; 76(8):1236-8. PubMed ID: 14578761
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P, Therapeutic Drug Monitoring Group of the French Pharmacological Society.
    Fundam Clin Pharmacol; 2006 Feb 27; 20(1):91-6. PubMed ID: 16448399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.